ENANTA PHARMACEUTICALS, INC Accrued Rent, Noncurrent
ENANTA PHARMACEUTICALS, INC (ENTA) had Accrued Rent, Noncurrent of $900.00 thousand as of 2019-09-30, per its 10-K filed 2020-11-25.
Discontinued › Notes
us-gaap:AccruedRentNoncurrent · last filed 2020-11-25
- 2019-09-30: Accrued Rent, Noncurrent $900.00K.
- 2019-06-30: Accrued Rent, Noncurrent $923.00K.
- 2019-03-31: Accrued Rent, Noncurrent $842.00K.
- 2018-12-31: Accrued Rent, Noncurrent $674.00K.
| Period end | Accrued Rent, Noncurrent |
|---|---|
| 2019-09-30 | $900.00K 10-K · filed 2020-11-25 |
| 2019-06-30 | $923.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $842.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $674.00K 10-Q · filed 2019-02-08 |
| 2018-09-30 | $593.00K 10-K · filed 2019-11-27 |
| 2018-06-30 | $611.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $632.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $654.00K 10-Q · filed 2018-02-09 |
| 2017-09-30 | $676.00K 10-K · filed 2018-11-29 |
| 2017-06-30 | $711.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $706.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $701.00K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $696.00K 10-K · filed 2017-12-11 |
| 2016-06-30 | $682.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $664.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $646.00K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $628.00K 10-K · filed 2016-12-09 |
| 2015-06-30 | $265.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $161.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $153.00K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $153.00K 10-K · filed 2015-12-11 |
| 2014-06-30 | $147.00K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $140.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $133.00K 10-Q · filed 2014-02-13 |
| 2013-09-30 | $127.00K 10-K · filed 2014-12-11 |
| 2013-06-30 | $114.00K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $101.00K 10-Q · filed 2013-05-15 |
| 2012-09-30 | $75.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |